18 Feb 2023 • Timely advise by doctors can make huge difference in getting the _right and timely treatments and avoid unnecessary hospitalisation _or delays which lead to life threatening event.  The manufacturer of the medical watch announced that its CardiacSense model has been approved by the Indian Regulatory Authority Central Drug Standard Control Organization (CDSCO), which is part of the Health Ministry of India. The product has previously received FDA approval in the United States and is one of only approved medical watches since it has accuracy levels higher than FDA defined thresholds. With its approval from CDSCO, the CardiacSense will be available in Indian markets soon. The company claims that its CardiacSense technology enables continuous monitoring of one's vital signs and prompts the user to immediately take an ECG and share it with a doctor for advice anytime the watch detects an increase or decrease in heart rate or an arrhythmia. CardiacSense is presently available in over 40 countries, including the USA, all of Europe, Australia, New Zealand, and numerous South American nations, and the latest addition is India.

Source: Financial Express | Read full story